Name | GSK3326595 |
---|---|
Synonyms |
6-[(1-Acetyl-4-piperidinyl)amino]-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-4-pyrimidinecarboxamide
4-Pyrimidinecarboxamide, 6-[(1-acetyl-4-piperidinyl)amino]-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]- EPZ-015938 |
Description | GSK3326595 is a potent, selective, reversible inhibitor of protein arginine methyltransferase 5 (PRMT5) with an IC50 of 6.2 nM. |
---|---|
Related Catalog | |
Target |
IC50: 6.2 nM (PRMT5)[1] |
In Vitro | GSK3326595 (EPZ015938), has entered clinical trials for the treatment of solid tumors and non-Hodgkin’s lymphoma[1]. |
References |
[1]. WO 2016022605 A1 |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 760.3±60.0 °C at 760 mmHg |
Molecular Formula | C24H32N6O3 |
Molecular Weight | 452.549 |
Flash Point | 413.6±32.9 °C |
Exact Mass | 452.253601 |
LogP | 2.88 |
Vapour Pressure | 0.0±2.7 mmHg at 25°C |
Index of Refraction | 1.626 |
Storage condition | -20℃ |